Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

227.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 240.00p
  • 52 Week Low: 166.40p
  • Currency: UK Pounds
  • Shares Issued: 60.11m
  • Volume: 123,578
  • Market Cap: £136.44m

Sales grow at Animalcare, but investment eats into profit

By Josh White

Date: Wednesday 10 Feb 2016

LONDON (ShareCast) - (ShareCast News) - Animalcare was looking at an increase in sales in its first half results on Wednesday, though profits were down in the six months to 31 December 2015 as the company pressed ahead with its investment strategy.
The AIM-traded supplier of veterinary medicine described progress as good during the period, with the firm achieving top line growth during a phase of significantly increased investment.

Revenue grew by 2% over the corresponding period a year earlier, to £7.11m, though profit before tax fell by 12.9% to £1.53m.

Basic underlying earnings per share fell by 8.8%, to 6.2p.

"The business has continued to perform well during the first six months of its financial year, with sales up by 2.7%, which is particularly pleasing against a very strong first half in FY15,," said chairman James Lambert.

"Given the top line growth during the period and increased levels of investment for the future success of Animalcare, the board remains confident about the prospects and outcome for the full year and beyond."

Animalcare saw solid revenue growth from its Licensed Veterinary Medicines group, up 4.2% to £4.58m against strong comparatives. The sector saw a £0.2m non-recurring benefit from sales of the Bluprecare product, as a result of supply issues at a competitor.

The company also launched a new mini microchip, and began its planned focus on exports which it said was already delivering a commercial benefit.

A continued focus on investment, in a bid to support future growth, was reflected by a £0.16m increase in overheads and a three-fold increase in product development pipeline expenditure to £0.6m.

Animalcare maintained a strong financial position, however, with group cash balances increasing by £0.32m to £6.1m since 30 June 2015.

The company announced an interim dividend of 1.8p per share, which was unchanged from a year earlier.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 227.00p
Change Today -9.00p
% Change -3.81 %
52 Week High 240.00p
52 Week Low 166.40p
Volume 123,578
Shares Issued 60.11m
Market Cap £136.44m

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.37% below the market average77.37% below the market average77.37% below the market average77.37% below the market average77.37% below the market average
1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average
Price Trend
49.08% above the market average49.08% above the market average49.08% above the market average49.08% above the market average49.08% above the market average
70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average
Income
77.92% below the market average77.92% below the market average77.92% below the market average77.92% below the market average77.92% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Jun-24 19-Oct-23
Paid 19-Jul-24 17-Nov-23
Amount 3.00p 2.00p

Trades for 07-May-2024

Time Volume / Share Price
15:36 5,524 @ 225.88p
15:03 5,000 @ 230.00p
14:52 5,000 @ 224.66p
14:50 5,000 @ 228.00p
14:48 5,000 @ 230.13p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page